Spanish drugmaker Grifols swung to a first-quarter net profit of 21 million euros ($23 million) from a year-ago loss, and ...

Grifols, a major player in global plasma extraction and processing, has experienced a significant 43% decline in stock price in 2024 following a bearish report from Gotham. KPMG and the Spanish ...

Hamilton councillors are hoping to deter a collection centre from opening in east Hamilton that would pay people for their ...

The City of Hamilton is one step closer to prohibiting private operators from running plasma collection centres in Hamilton. The Voluntary Blood Donations Act bans the practice, however, there is an ...

Grifols reveals earnings for Q1 on May 14. Wall Street analysts are expecting earnings per share of $0.106. Follow Grifols stock price in real-time on Markets Insider here. On May 14, Grifols will ...

Grifols SA shares fell after short-seller Gotham City Research released a new report accusing the healthcare company of transferring funds from its shareholders to a vehicle held by former executives.

GRIFOLS transfer bags are used for sterile preservation and administration of blood components. Blood components can be obtained, stored and preserved without contact with the environment ensuring ...

Grifols will be reporting earnings Q1.Wall Street predict expect Grifols will report earnings per share of €0.098Go here to follow ...

Deutsche Bank raised the price target for the Grifols SA ADR (NASDAQ:GRFS) stock from “a Hold” to “a Sell”. The rating was released on March 12, 2024, according to finviz.

Grifols, S.A. operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally. The company provides immunoglobulin to treat immunodeficiencies; albumin used to ...

Grifols reported 4.1% revenue growth (5.5% at constant currencies) in the first quarter of 2024, as solid 9.4% constant currency growth in the biopharma division was countered by declines in ...

BARCELONA (Reuters) - Spanish drugmaker Grifols swung to a first-quarter net profit of 21 million euros ($23 million) from a year-ago loss, and said on Tuesday it was on track to meet its 2024 ...